RACK1 and ovarian cancer: Ovarian cancer cells expressing RACK1-Mut or treated with PARP14i exhibited slower growth than cells expressing RACK1-WT or treated with vehicle in the presence of thapsigargin or carboplatin (Fig. 4, A and B; and Fig. S3, A–D).